Funds holding CELLECTIS SA
ISIN US15117K1034 · France · LEI 5493000KKX5VQ37Q2W83
- Fund holders
- 2
- Of which ETFs
- 1 1 other fund
- Value held
- 1.3M $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 226,875 | 680.6K $ | 0.09 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 223,114 | 669.3K $ | 0.01 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.09 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | 0 | 449,989 | -20.6 % |
| 2026Q2 | 2 | 0 | 566,748 | +0.4 % |
| 2026Q1 | 2 | +1 | 564,326 | +148.7 % |
| 2025Q4 | 1 | 0 | 226,875 | 0.0 % |
| 2025Q3 | 1 | -5 | 226,875 | -32.4 % |
| 2025Q2 | 6 | -3 | 335,531 | -85.7 % |
| 2025Q1 | 9 | -2 | 2,346,265 | -10.4 % |
| 2024Q4 | 11 | 0 | 2,619,310 | -3.2 % |
| 2024Q3 | 11 | -1 | 2,704,945 | -5.4 % |
| 2024Q2 | 12 | +2 | 2,858,016 | +4.9 % |
| 2024Q1 | 10 | -2 | 2,723,549 | -8.6 % |
| 2023Q4 | 12 | 2,980,893 |
Institutional managers
31 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| B Group, Inc. | 3,281,501 | 10.4M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,178,620 | 10.1M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 2,744,098 | 8.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 341,523 | 1.1M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 226,875 | 719K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 86,776 | 275.1K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 84,345 | 267.4K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 65,942 | 209K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 44,315 | 140.5K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 41,112 | 130.3K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 41,000 | 130K $ | as of Mar 31, 2026 |
| UBS Group AG | 29,774 | 94.4K $ | as of Mar 31, 2026 |
| Delaney Dennis R | 24,000 | 76.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 16,269 | 51.6K $ | as of Mar 31, 2026 |
| RHUMBLINE ADVISERS | 15,085 | 47.8K $ | as of Mar 31, 2026 |
| Lido Advisors, LLC | 10,094 | 32K $ | as of Mar 31, 2026 |
| HARBOUR INVESTMENTS, INC. | 4,500 | 14.3K $ | as of Mar 31, 2026 |
| NATIONAL BANK OF CANADA /FI/ | 3,600 | 11.1K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 3,150 | 10K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,797 | 5.7K $ | as of Mar 31, 2026 |
| Atlantic Union Bankshares Corp | 1,500 | 4.8K $ | as of Mar 31, 2026 |
| QUADRANT CAPITAL GROUP LLC | 944 | 3K $ | as of Mar 31, 2026 |
| GAMMA Investing LLC | 734 | 2.3K $ | as of Mar 31, 2026 |
| Allworth Financial LP | 500 | 1.6K $ | as of Mar 31, 2026 |
| POM Investment Strategies, LLC | 495 | 1.6K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding CELLECTIS SA". https://titelia.com/en/stocks/cellectis-sa-US15117K1034